7 clinical symptoms of drug addiction withdrawal 

Withdrawal is not a brief, inconvenient stage on the road to recovery.

It is a clinically volatile, high-risk phase that demands structured medical oversight and nuanced understanding. The acute cessation of drug or alcohol use triggers a cascade of physiological and neurochemical changes¹ which, if mismanaged, can lead to medical emergencies, psychiatric destabilisation, or relapse.

In England alone, almost 300,000 adults were in contact with drug and alcohol services in 2023², with opioids, alcohol, and benzodiazepines accounting for the majority of withdrawal-related admissions. Yet these figures likely underrepresent the broader scope of individuals experiencing withdrawal in private or underreported contexts³ – particularly those for whom reputation, career, or cultural stigma can suppress open disclosure⁴.

The severity and presentation of withdrawal symptoms depend on multiple variables: the substance(s) involved, dose and duration of use, individual physiology, coexisting mental health conditions, and withdrawal setting. Symptoms may be mild and flu-like, or severe and life-threatening – including seizures, psychosis, or cardiovascular collapse.

Withdrawal is also a neurological turning point. During dependence, neuroadaptations in GABAergic, dopaminergic, and noradrenergic pathways mask underlying dysregulation. Abrupt cessation unmasks this dysfunction, resulting in a neurobiological rebound⁵ that can include extreme autonomic hyperactivity, affective instability, and cognitive disturbance.

Have a client who might benefit from discreet, curated, whole-person support in managing addiction?

Make a referral today →

Symptom 1 – autonomic hyperactivity and cardiovascular stress

Among the earliest and most physiologically destabilising manifestations of drug withdrawal is a surge in autonomic activity⁶ – particularly pronounced in alcohol, benzodiazepine, and opioid withdrawal syndromes.

This response arises from the sudden unopposed activation of the sympathetic nervous system following the removal of CNS depressants or modulators.

Patients may present with:

• Elevated heart rate and tachycardia
• Hypertension, often severe and sustained
• Hyperthermia, chills, and excessive sweating
• Dilated pupils, tremor, and restlessness
• Rebound insomnia and emotional agitation

These symptoms⁷ are prognostically significant. In alcohol withdrawal, marked autonomic instability may precede delirium tremens (DTs)⁸, a medical emergency with a mortality rate of up to 15% if untreated. In benzodiazepine withdrawal, cardiovascular stress can be compounded⁹ by concurrent seizure risk, while opioid withdrawal, though typically not life-threatening in isolation, still places considerable strain on vulnerable cardiovascular systems.

Clinical red flags in this symptom domain – such as new-onset chest pain, confusion, or escalating agitation – require immediate escalation and, often, inpatient medical detox. These autonomic markers may be the first objective signs that withdrawal is underway¹⁰.

Symptom 2 – gastrointestinal disturbance and metabolic disruption

While often considered less serious than cardiac or psychiatric withdrawal symptoms, gastrointestinal and metabolic disturbances can rapidly become debilitating¹¹, particularly in individuals with underlying nutritional deficits or comorbid medical conditions.

Nausea, vomiting, and diarrhoea

These hallmark symptoms are especially common in opioid, alcohol, and stimulant withdrawal¹². They arise from withdrawal-induced changes to enteric nervous system regulation and neurotransmitter imbalance (notably in dopamine and serotonin). Chronic drug use disrupts gut motility; withdrawal triggers a sudden, dysregulated rebound.

Beyond discomfort, the clinical consequences include:

• Volume depletion and risk of hypovolemic shock
• Electrolyte imbalances (e.g. hypokalaemia, hyponatraemia)
• Nutrient malabsorption and early cachexia in vulnerable patients

Appetite dysregulation and weight fluctuation

The acute withdrawal phase is frequently accompanied by anorexia or, conversely, hyperphagia¹³: the latter particularly common after stimulant cessation. In both cases, this reflects dysregulated hypothalamic signalling and can contribute to emotional instability, fatigue, and somatic complaints.

Symptom 3 – neuropsychiatric symptoms and affective dysregulation

The neuropsychiatric impact of drug withdrawal often emerges before somatic symptoms fully subside. Withdrawal unearths a dysregulated affective baseline – the suppressed or chemically modulated emotional states that have been masked during prolonged substance use¹⁴. These symptoms are diagnostically complex, often mimicking primary psychiatric illness and requiring careful longitudinal assessment.

Common neuropsychiatric presentations include¹⁵:

• Irritability and emotional lability
• Generalised anxiety, panic attacks, and intrusive thoughts
• Depressed mood, anhedonia, and suicidal ideation
• Paranoia, agitation, and in some cases, transient psychotic episodes

In stimulant withdrawal (e.g. cocaine, methamphetamine), these symptoms can be severe and prolonged, with users commonly experiencing profound dysphoria and emotional flatness¹⁶; often misinterpreted as treatment failure rather than expected withdrawal trajectory. In benzodiazepine and alcohol withdrawal, psychiatric destabilisation can escalate rapidly and unpredictably¹⁷.

Clinicians must also remain alert to underlying mood or trauma-related disorders that emerge once substance use is interrupted. Differentiating between substance-induced mood disturbance and primary affective pathology is critical to long-term care planning.

Symptom 4 – insomnia and circadian rhythm disruption

Disturbed sleep is not only a hallmark of acute withdrawal – it is one of the most persistent and destabilising sequelae¹⁸, often continuing for weeks or months after cessation. Nearly every class of addictive drug – stimulants, opioids, alcohol, benzodiazepines – alters the body’s circadian regulatory systems¹⁹, either through direct CNS effects or by chronically disrupting REM and slow-wave sleep architecture.

What sleep disruption looks like in withdrawal

• Initial insomnia: difficulty falling asleep, especially in stimulant withdrawal
• Middle insomnia: frequent waking and fragmented sleep (commonly seen in opioid or alcohol withdrawal)
• REM rebound: vivid dreams, nightmares, or night terrors after cessation of substances like alcohol or GHB
• Daytime hypersomnia: often reported during early abstinence from cocaine or amphetamines

Chronic sleep loss feeds into a negative feedback loop of emotional dysregulation, fatigue, and reduced relapse resilience. Sleep deprivation may also exacerbate cardiovascular strain²⁰, psychiatric symptoms, and cognitive slowing, compounding other withdrawal challenges.

Symptom 5 – cognitive impairment and anhedonia

Withdrawal is often mistakenly viewed as purely physical²¹, but many patients describe the cognitive and emotional flattening that follows cessation as the most distressing of all.

In early abstinence (particularly following chronic stimulant, benzodiazepine, or opioid use) individuals may experience:

• Executive dysfunction: impaired planning, focus, and task completion
• Working memory deficits: difficulty retaining or manipulating information
• Blunted affect and anhedonia: a loss of ability to experience pleasure or motivation

These symptoms reflect a neurochemical lag, particularly involving dopaminergic depletion and frontal-limbic dysregulation. The nucleus accumbens – central to reward processing – has been conditioned to respond only to substance-driven stimuli²². During withdrawal, everyday experiences feel emotionally muted or meaningless.

This state of affective and cognitive dullness is not pathological in itself but, rather, it is expected. However, without clinical support and psychoeducation, many individuals misinterpret it as permanent or unbearable, increasing the risk of early relapse.

Symptom 6 – drug cravings and compulsive ideation

Craving is both a neurobiological phenomenon and a psychological event and, in withdrawal, it often surfaces with unrelenting intensity²³.

At the neurochemical level²⁴, craving is driven by:

• Dopamine receptor downregulation in mesolimbic pathways
• Glutamatergic hyperexcitability
• Persistent cue-induced limbic activation

Patients may describe vivid mental imagery, intrusive thoughts about drug use, or an overwhelming urge to relieve dysphoria through reinstatement of use. Deeper than ‘bad habits’ these symptoms are hardwired compulsive ideation loops, reinforced by years of substance conditioning.

Craving intensity is highest during:

• The first 3–7 days of acute withdrawal²⁵
• Periods of stress, isolation, or sleep deprivation
• Exposure to environmental cues (e.g. locations, objects, people associated with prior use)²⁶

Clinically, cravings can function as a key relapse driver²⁷, especially when misinterpreted as a sign of treatment failure.

Symptom 7 – psychotic features or perceptual disturbances

Though not universal, psychotic symptoms during withdrawal should never be dismissed as incidental²⁸. They require immediate clinical attention and thorough diagnostic scrutiny.

Psychotic features may include:

• Auditory hallucinations²⁹ (often derogatory or paranoid)
• Visual or tactile hallucinations³⁰ (e.g. formication in stimulant withdrawal)
• Delusional thinking or disorganised speech
• Derealisation or depersonalisation

These symptoms are most common in:

• Severe alcohol withdrawal (e.g. alcoholic hallucinosis, delirium tremens)
• Stimulant withdrawal (particularly methamphetamine and crack cocaine)
• Poly-drug detoxes, where pharmacological complexity clouds neurochemical rebalancing

Differentiating between substance-induced psychosis and an emerging primary psychotic disorder³¹ is crucial. Timing of symptom onset, resolution with abstinence, and patient history will inform clinical interpretation.

Final reflections: withdrawal treatment, best-practice care, and why withdrawal is a whole-system challenge

Withdrawal is not a linear detoxification process. It is a neurological, psychological, and systemic recalibration that demands precise clinical intervention.

The symptoms outlined above, ranging from autonomic instability to psychotic features, reflect how deeply substance use disorders imprint themselves on the central nervous system, the neuroendocrine axis, and the psycho-behavioural framework of an individual’s life.

Critically, withdrawal is also a whole-system challenge:

• Clinically, it involves multidisciplinary coordination between psychiatry, internal medicine, psychology, and nursing.
• Emotionally, it surfaces vulnerability, shame, and the often-fragmented identity left in the wake of long-term substance use.
• Practically, it requires robust discharge planning, risk mitigation, and often, family or occupational liaison.

At Harbor London, our approach to managing withdrawal symptoms is grounded in medical excellence, but defined by individualisation. We treat one client at a time, offering 24/7 support in one’s own private residential setting, curated around each individual’s neurobiology, history, and therapeutic goals. There is no standardised protocol – rather, whole-person, evidence-based care, informed by current best practice and delivered with total discretion.

For healthcare professionals, recognising the early warning signs of withdrawal and referring to the right setting – particularly for high-functioning individuals who may minimise or mask symptoms – can be lifesaving. Symptoms such as sustained hypertension, vivid dreams, affective flattening, or compulsive drug ideation are never trivial. They are clinical data points, indicating a system in flux.

Withdrawal is not the end of the problem; nor is it the beginning of the solution. But it is a pivot point: the juncture at which physiology, psychology, and environment collide. Getting this phase right sets the foundation for meaningful, lasting recovery.

Contact us today to learn more about addiction treatment at Harbor.

References

1. https://www.ncbi.nlm.nih.gov/books/NBK424849/#:~:text=This%20stage%20of%20addiction%20involves,emotional%20state%20associated%20with%20withdrawal.
2. https://www.gov.uk/government/statistics/substance-misuse-treatment-for-adults-statistics-2022-to-2023/adult-substance-misuse-treatment-statistics-2022-to-2023-report
3. https://www.ucl.ac.uk/news/2025/may/antidepressant-withdrawal-symptoms-more-common-among-long-term-users
4. https://www.bbc.co.uk/programmes/articles/3mYWz4J9LJp7jGV3LyB2clW/9-major-stars-who-spoke-openly-about-their-addiction-problems
5. https://www.nature.com/articles/s41386-024-01857-8
6. https://academic.oup.com/braincomms/article/1/1/fcz025/5588408
7. https://www.ncbi.nlm.nih.gov/books/NBK459239/
8. https://www.oxfordhealthformulary.nhs.uk/docs/Guidelines%20for%20the%20management%20of%20alcohol%20dependendence%20-%20Dec%202020_RH.pdf
9. https://pubmed.ncbi.nlm.nih.gov/21815323/
10. https://pmc.ncbi.nlm.nih.gov/articles/PMC7017784/
11. https://pmc.ncbi.nlm.nih.gov/articles/PMC5369702/
12. https://adai.uw.edu/pubs/pdf/2021opioidsstimulants.pdf
13. https://www.researchgate.net/publication/303810354_Drug_Withdrawal_and_Hyperphagia#:~:text=This%20endogenous%20reward%20system%20is,during%20recovery%20from%20substance%20abuse.
14. https://pmc.ncbi.nlm.nih.gov/articles/PMC7425303/
15. https://www.sciencedirect.com/science/article/pii/S2352853222000165
16. https://pmc.ncbi.nlm.nih.gov/articles/PMC10069411/
17. https://pmc.ncbi.nlm.nih.gov/articles/PMC4606320/
18. https://ascpjournal.biomedcentral.com/articles/10.1186/s13722-016-0056-7
19. https://pmc.ncbi.nlm.nih.gov/articles/PMC4041815/
20. https://pmc.ncbi.nlm.nih.gov/articles/PMC2845795/
21. https://pmc.ncbi.nlm.nih.gov/articles/PMC4654762/
22. https://pmc.ncbi.nlm.nih.gov/articles/PMC10503809/#:~:text=The%20nucleus%20accumbens%20(NAc)%20is%20a%20primary%20site%20that%20orchestrates,behaviors%20(8%2C%209).
23. https://pmc.ncbi.nlm.nih.gov/articles/PMC4041083/
24. https://pmc.ncbi.nlm.nih.gov/articles/PMC3735834/
25. https://pmc.ncbi.nlm.nih.gov/articles/PMC2683662/
26. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2793124
27. https://aeon.co/essays/why-the-pull-of-addictive-cravings-is-so-hard-to-resist
28. https://americanaddictioncenters.org/co-occurring-disorders/drug-psychosis-comorbidity
29. https://www.northpointcolorado.com/rehab-blog/detox-hallucinations-and-alcohol-withdrawal-delirium/
30. https://my.clevelandclinic.org/health/symptoms/23960-tactile-hallucinations-formication
31. https://pubmed.ncbi.nlm.nih.gov/22321667/